Arena Pharmaceuticals to Release First Quarter 2021 Financial Results and Provide Corporate Update on May 5
April 28 2021 - 4:05PM
Business Wire
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its
first quarter 2021 financial results and provide a corporate update
on Wednesday, May 5, 2021, after the close of the U.S. financial
markets. The Company will host a question and answer session via
conference call and live webcast with the investment community the
same day at 4:30 PM ET.
Conference Call & Webcast Information When:
Wednesday, May 5, 2021, at 4:30 PM ET Dial-in: (877) 643-7155
(United States) or (914) 495-8552 (International) Conference ID:
4329177
Please join the conference call at least 20 minutes early to
register. You can access the live webcast under the investor
relations section of Arena's website. A replay of the conference
call will be archived for 30 days after the call.
About Arena Pharmaceuticals
ARENA Pharmaceuticals is a team with a singular purpose –
deliver important medicines to patients.
In a rapidly changing global market, we work with a sense of
urgency every day to understand the needs of all our stakeholders,
identify bold, sometimes disruptive, ideas to get medicines to
patients, and relentlessly execute until it’s done.
ARENA - Care More. Act Differently.
Forward-Looking Statements
Certain statements in this press release are forward-looking
statements that involve a number of risks and uncertainties. Such
forward-looking statements include statements about Arena's
position, drive, portfolio, prioritization, financial position,
team, and building of the company. For such statements, Arena
claims the protection of the Private Securities Litigation Reform
Act of 1995. Actual events or results may differ materially from
Arena's expectations. Factors that could cause actual results to
differ materially from the forward-looking statements include those
disclosed in Arena's filings with the Securities and Exchange
Commission. These forward-looking statements represent Arena's
judgment as of the time of this release. Arena disclaims any intent
or obligation to update these forward-looking statements, other
than as may be required under applicable law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210428005002/en/
Patrick Malloy Arena Pharmaceuticals, Inc. Vice President,
Investor Relations & Corporate Communications
pmalloy@arenapharm.com 847.987.4878
Arena Pharmaceuticals (NASDAQ:ARNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arena Pharmaceuticals (NASDAQ:ARNA)
Historical Stock Chart
From Apr 2023 to Apr 2024